• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视用于治疗癌症恶病质的老药:醋酸甲地孕酮。

A new look at an old drug for the treatment of cancer cachexia: megestrol acetate.

机构信息

Cancer Research Group, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Diagonal 645, 08028-Barcelona, Spain.

出版信息

Clin Nutr. 2013 Jun;32(3):319-24. doi: 10.1016/j.clnu.2013.01.004. Epub 2013 Jan 22.

DOI:10.1016/j.clnu.2013.01.004
PMID:23395103
Abstract

Cachexia is a multiorganic syndrome associated with cancer, characterized by body weight loss, muscle and adipose tissue wasting and inflammation, being often associated with anorexia. The aim of the present review is to examine the impact of megestrol acetate in the treatment of cancer cachexia, both at the biochemical and physiological level taking into account new experimental data related to protein muscle metabolism. Based on experimental evidence, it is concluded that megestrol acetate is a good candidate for muscle wasting treatment and future studies addressed at the interaction between the drug and protein turnover in human skeletal muscle should be performed.

摘要

恶病质是一种与癌症相关的多器官综合征,其特征是体重下降、肌肉和脂肪组织消耗以及炎症,常伴有厌食。本综述的目的是检查醋酸甲地孕酮在治疗癌症恶病质中的作用,从生化和生理水平考虑与肌肉蛋白代谢相关的新实验数据。基于实验证据,结论认为醋酸甲地孕酮是治疗肌肉消耗的一个很好的候选药物,应该进行针对该药物与人类骨骼肌蛋白周转率之间相互作用的进一步研究。

相似文献

1
A new look at an old drug for the treatment of cancer cachexia: megestrol acetate.重新审视用于治疗癌症恶病质的老药:醋酸甲地孕酮。
Clin Nutr. 2013 Jun;32(3):319-24. doi: 10.1016/j.clnu.2013.01.004. Epub 2013 Jan 22.
2
Megestrol acetate: its impact on muscle protein metabolism supports its use in cancer cachexia.醋酸甲地孕酮:其对肌肉蛋白代谢的影响支持其在癌性恶病质中的应用。
Clin Nutr. 2010 Dec;29(6):733-7. doi: 10.1016/j.clnu.2010.06.003.
3
The potential of ghrelin in the treatment of cancer cachexia.Ghrelin 在癌症恶病质治疗中的潜力。
Expert Opin Biol Ther. 2013 Jan;13(1):67-76. doi: 10.1517/14712598.2013.727390. Epub 2012 Oct 18.
4
[Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].[克罗地亚关于二十碳五烯酸和醋酸甲地孕酮在癌症恶病质综合征中应用的指南]
Lijec Vjesn. 2007 Dec;129(12):381-6.
5
Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome.卡尼汀联合塞来昔布±美司坦醋酸治疗癌症相关性厌食/恶病质综合征的随机 III 期临床试验。
Clin Nutr. 2012 Apr;31(2):176-82. doi: 10.1016/j.clnu.2011.10.005. Epub 2011 Nov 1.
6
Megestrol acetate for cancer anorexia/cachexia #100.醋酸甲地孕酮用于癌症厌食/恶病质#100。
J Palliat Med. 2006 Jun;9(3):803-4.
7
Megestrol acetate-probably less effective than has been reported!醋酸甲地孕酮——可能不如所报道的那么有效!
J Pain Symptom Manage. 2005 Jul;30(1):4; author reply 5-6. doi: 10.1016/j.jpainsymman.2005.05.003.
8
Megestrol acetate NCD oral suspension -- Par Pharmaceutical: megestrol acetate nanocrystal dispersion oral suspension, PAR 100.2, PAR-100.2.醋酸甲地孕酮非专利口服混悬液——帕尔制药公司:醋酸甲地孕酮纳米晶体分散口服混悬液,PAR 100.2,PAR - 100.2。
Drugs R D. 2007;8(4):251-4. doi: 10.2165/00126839-200708040-00005.
9
The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).醋酸甲地孕酮对癌症和艾滋病患者厌食、体重减轻及恶病质的影响(综述)
Anticancer Res. 1997 Jan-Feb;17(1B):657-62.
10
Megestrol acetate for treatment of anorexia-cachexia syndrome.醋酸甲地孕酮治疗恶病质综合征。
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD004310. doi: 10.1002/14651858.CD004310.pub3.

引用本文的文献

1
Alpha-Ketoisocaproate Attenuates Muscle Atrophy in Cancer Cachexia Models.α-酮异己酸减轻癌症恶病质模型中的肌肉萎缩。
J Cachexia Sarcopenia Muscle. 2025 Aug;16(4):e70044. doi: 10.1002/jcsm.70044.
2
Ovarian hormones and eating disorders.卵巢激素与饮食失调。
Front Psychol. 2024 Sep 9;15:1467795. doi: 10.3389/fpsyg.2024.1467795. eCollection 2024.
3
Dose-dependent effect of megestrol acetate supplementation in cancer patients with anorexia-cachexia syndrome: A meta-analysis.醋酸甲地孕酮补充治疗癌症厌食-恶病质综合征患者的剂量依赖性效应:一项荟萃分析。
J Cachexia Sarcopenia Muscle. 2024 Aug;15(4):1254-1263. doi: 10.1002/jcsm.13500. Epub 2024 Jun 20.
4
Comparison of the pharmacokinetic characteristics and bioequivalence between two nanosuspension formulations of megestrol acetate in healthy Korean male subjects.醋酸甲地孕酮两种纳米混悬液制剂在健康韩国男性受试者中的药代动力学特征及生物等效性比较。
Transl Clin Pharmacol. 2024 Mar;32(1):63-72. doi: 10.12793/tcp.2024.32.e6. Epub 2024 Mar 26.
5
Clinical implication of megestrol acetate in metastatic gastric cancer: a big data analysis from Health Insurance Review and Assessment (HIRA) database.甲地孕酮醋酸酯在转移性胃癌中的临床意义:来自健康保险审查和评估(HIRA)数据库的大数据分析。
Support Care Cancer. 2024 Mar 26;32(4):249. doi: 10.1007/s00520-024-08430-5.
6
Jianpi Decoction Combined with Medroxyprogesterone Acetate Alleviates Cancer Cachexia and Prevents Muscle Atrophy by Directly Inhibiting E3 Ubiquitin Ligase.健脾汤联合醋酸甲羟孕酮通过直接抑制 E3 泛素连接酶缓解癌性恶病质和预防肌肉萎缩。
Chin J Integr Med. 2024 Jun;30(6):499-506. doi: 10.1007/s11655-023-3702-4. Epub 2023 Aug 24.
7
Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management.癌症相关性恶病质——了解肿瘤的宏观环境和微观环境以改善管理。
Nat Rev Clin Oncol. 2023 Apr;20(4):250-264. doi: 10.1038/s41571-023-00734-5. Epub 2023 Feb 20.
8
Meta-Analysis of Pharmacological, Nutraceutical and Phytopharmaceutical Interventions for the Treatment of Cancer Related Fatigue.用于治疗癌症相关疲劳的药理学、营养保健品及植物药干预措施的荟萃分析
Cancers (Basel). 2022 Dec 23;15(1):91. doi: 10.3390/cancers15010091.
9
A Systematic Review and Meta-Analysis of the Clinical Use of Megestrol Acetate for Cancer-Related Anorexia/Cachexia.醋酸甲地孕酮用于癌症相关性厌食/恶病质临床应用的系统评价与Meta分析
J Clin Med. 2022 Jun 28;11(13):3756. doi: 10.3390/jcm11133756.
10
MicroRNAs: Novel players in the diagnosis and treatment of cancer cachexia (Review).微小RNA:癌症恶病质诊断与治疗中的新角色(综述)
Exp Ther Med. 2022 May 16;24(1):446. doi: 10.3892/etm.2022.11373. eCollection 2022 Jul.